Biotech Values

[Mufaso]

VKTX has a major event at Obesity Week on Sunday at 7:30 PM where they will disclose info VK2735 on the oral doses up to 100mg (only disclosed up to 40mg QD so far) and data from the Subq phase 2 Venture study (minimally expect more pK data plus lipids info). Expect volatility today and especially on Monday.

https://ir.vikingtherapeutics.com/2024-10-28-Viking-Therapeutics-to-Highlight-Clinical-Data-from-VK2735-Obesity-Program-in-Presentations-at-ObesityWeek-R-2024